Naratuximab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade

Reference:
Product nameNaratuximab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
SourceCAS 1622327-39-2
SpeciesChimeric
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsNaratuximab,K7153A,CD37, TSPAN26,anti-CD37, TSPAN26
ReferencePX-TA1419
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Naratuximab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade

General information on Anti-CD37/TSPAN26[Homo sapiens] (Naratuximab) Monoclonal Antibody

Naratuximab is investigated for the treatment of Relapsed or Refractory Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Naratuximab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

C-type lectin domain family 9 member A(CLEC9A)
Antigen

C-type lectin domain family 9 member A(CLEC9A)

PX-P4353 210€
Stable Isotope Labelled Naratuximab Biosimilar – Anti-CD37/TSPAN26 mAb – Research Grade
SIL

Stable Isotope Labelled Naratuximab Biosimilar – Anti-CD37/TSPAN26 mAb – Research Grade

PX-TA1419-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products